Other Clients/Companies To Watch:
Access Pharmaceuticals,
Inc
(OTC: ACCP)
Alexza
Pharmaceuticals, Inc.
(NASDAQ:ALXA)
Cardiogenics Holdings,
Inc.
(OTC:CGNH)
Crucell
N.V.
(Euronext, NASDAQ: CRXL)
Digital
Angel Corporation
(AMEX:DOC)
Dynavax Technologies
Corporation
(NASDAQ:DVAX)
KERYX Biopharmaceuticals,
Inc.
(NASDAQ:KERX)
Manhattan Pharmaceuticals,
Inc.
(AMEX:MHA)
Mediware Information Systems, Inc. (NASDAQ: MEDW)
Redpoint Bio Corporation
(OTC:RPBC)
 |
| Dr. Carlton E. Turner - CEO |
Carrington Laboratories, Inc., is an ISO-certified, research-based biopharmaceutical and consumer products company currently utilizing naturally occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care as well as to manufacture and market the nutraceutical raw materials Manapol® and Hydrapol(TM). Carrington Laboratories also manufactures and markets consumer products sold under its AloeCeuticals® brand and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. More than 120 patents in 26 countries protect Carrington Laboratories' technology. Select products are honored with the internationally coveted CE mark, recognized by more than 20 countries around the world.